Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Actelion announces positive results of the MERIT study with macitentan in patients with chronic thromboembolic pulmonary hypertension
ALLSCHWIL/BASEL, Switzerland November 7, 2016 I Actelion Ltd (SIX.
Regorafenib from Bayer Submitted to Health Authorities Seeking Approval in Second-Line Treatment of Liver Cancer
BERLIN, Germany I November 7, 2016 I Bayer today announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor regorafenib in the U.
Pancreatic cancer set to become third biggest cancer killer in EU next year
The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU in 2017, a study has found.
Drugmakers under fire for suspected US price fixing
Two prominent US lawmakers on Thursday called on US federal antitrust regulators to probe whether Sanofi SA, Eli Lilly and Co, Merck & Co Inc and Novo Nordisk A/S colluded to set prices for insuli...
Why is Valeant's 'blockbuster' libido drug Addyi a dud? Shoddy marketing, investor lawsuit claims
When Valeant bought Sprout Pharmaceuticals and its controversial female libido drug Addyi, it agreed to a marketing blitz that would bring royalties to Sprout's former shareholders.
Allergan's handling of Q3 'black eye' dings confidence in management: Analyst
Allergan’s third-quarter numbers weren’t good.
FDA savages Chinese API maker in warning letter
The FDA has savaged a Chinese API maker in a warning letter for a long list of violations, including hiding questionable products, lying to inspectors about products made at the Beijing plant and syst...
Lundbeck raises its 2016 financial guidance based on improved sales and profitability
Revenue reached DKK 11,469 million in the first nine months of 2016 representing an increase of 6% compared to the same period last year Revenue in the US increased 33%...
Brexit threatens supply of new drugs, report warns
British patients could end up not being able to access modern medicines if there is a "hard Brexit", a think tank report endorsed by a former Conservative health minister warned on Wednesday...
Teva asks FDA to raise the bar on new Copaxone copies
Teva may be at a court’s mercy when it comes to IP protection for its long-lasting multiple sclerosis therapy, Copaxone.
ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation
SAN DIEGO, CA, USA I October 31, 2016 I ACADIA Pharmaceuticals Inc.
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
CAMBRIDGE, MA, USA I October 31, 2016 I ARIAD Pharmaceuticals, Inc.
584
585
586
587
588
589
590
591
592
